Delivery Order SPE2DB20D2104-SPE2DB23FS17Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorouracil 0.5% cream in 30 gram quantities. The $2,352.07 firm fixed-price delivery order was made under a broader Indefinite Delivery Contract (IDC) with Cencora, Inc. (doing business as Amerisourcebergen) valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
- This federal contract award, valued at $2,336.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of FLUOROURACIL 5% CREAM 40GM, a medical product used for various healthcare applications. The contract has an ultimate completion date of November 18, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of FLUOROURACIL 0.5% CREAM 30GM. The $1,809.16 Firm Fixed Price contract has a completion date of December 6, 2022. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables the DLA to...
- This federal contract award, valued at $1,761.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4568223554 - FLUOROURACIL 5% CREAM 40GM, with a period of performance extending through May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,274.86 firm fixed-price contract is for the delivery of 4555497530 - Fluorouracil 0.5% Cream 30GM, a pharmaceutical product. The contract has a completion date of November 23, 2021 and was awarded on November 22, 2021. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluorouracil 5% Cream 40GM. The contract has a potential value of $2,116.86 and a completion date of February 29, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a prime contractor for DLA, providing a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluorouracil 5% cream in 40-gram units. This is a firm fixed-price contract with a ceiling value of $1,558.48 and an ultimate completion date of August 13, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,251.38, is for the procurement of Fluocinolone 0.01% Cream, a medical product used in various healthcare applications. The contract is a Firm Fixed Price type, with an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,997.08 firm fixed-price contract is for the delivery of 1.1% sodium fluoride cream, 51 grams, with a performance period through December 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $1,676.21. The contract is for the supply of FLUORESCITE 10% VIAL 5ML, a medical product, to the Defense Logistics Agency, a defense agency. The contract is not set aside and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS17ZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $4,425.42 delivery order is for the provision of Fluorouracil 0.5% Cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 14, 2023 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities across multiple therapeutic areas. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 2/13/23 |